2018台灣生技月 Bio Taiwan 生物科技大展

2018 台灣生技月 南港展覽館

PROGRAM

BioBusiness Asia Conference 2018

​​

July 18  (Wednesday)

Venue: 3F, Bldg. A, CTBC Financial Park

08:30 – 09:00

Registration

BBA Plenary Session – Global Development in Biotechnology

Ballroom A

09:00 – 09:05

Welcoming Remarks
Johnsee Lee, Chairman, Taiwan Bio Industry Organization

09:05 – 09:20

Opening Remarks

09:20 – 09:55

Fact & Fiction about GMOs and Future of Biotechnology
Sir Richard Roberts, Nobel Laureate, CSO, New England Biolabs

09:55 – 10:25

Healthcare 2025: Global Transformations and Disruptions
Reenita Das, Senior Partner & SVP, Transformation Health, Frost & Sullivan

10:25 – 10:40

Break

10:40 – 11:10

Global Policies and Strategies in Shaping Biotech Landscape
Joseph Damond, Executive Vice President, International Affairs, Biotechnology Innovation Organization (BIO)

11:10 - 11:40

Healthcare Investment Opportunities in Asia
Miron Lila, Director, Asia Healthcare Investment Banking, Citigroup

11:40 – 12:15

Panel Discussion
Moderator: Johnsee Lee, Chairman, Taiwan Bio Industry Organization
Panelists: all speakers above 

 

Luncheon - Taiwan as a Biotech Innovation Hub in Asia Pacific

Ballroom A

12:25 – 12:30 Opening Remarks
12:30 – 13:00 Strategies and Initiatives for Taiwan Biotech Industry
13:00 – 13:30 Recent Development in Regional Biotech Collaborations
13:30 – 14:00 Panel Discussion

 

July 18 (Wednesday)

Venue: 3F, Bldg. A, CTBC Financial Park

BBA Session 1 – Integrating Technologies for Healthcare Applications

Ballroom A

14:10 – 14:15

Opening Remarks
Session Chair: Timothy Lu, Associate Professor, MIT

14:15 – 14:40

Intersection of Biology and Computation for Accelerated Drug Discovery
Jeffrey Lu, CEO & Co-Founder, Engine Biosciences

14:40 – 15:05

Integrating Hospitals and Homes of the Future with IoT, Big Data, Ai and Mobile Technology
Jason Wang, Co-founder, MedicusTek

15:05 – 15:30

Technology Platforms for Clinical Surveillance & Training
Sharon Fernando, Senior Clinical Scientist, Clinical Surveillance & Training, APAC Region, Syneos Health

15:30 – 16:05

Panel Discussion
Moderator: Timothy Lu, Associate Professor, MIT
Panelists: all speakers above 

16:05 – 16:20 Break

 

BBA Session 2 – Biologic Product and Process Development

Ballroom B

14:10 – 14:15

Opening Remarks
Session Chair: Lee-Cheng LC Liu, President & CEO, EirGenix

14:15 – 14:45 Developing Biologics through Partnerships and Collaboration
Joe McCracken, VP Businest Development of Alkahest; Former Head of Global Business Development & Licensing of Roche-Genentech

14:45 – 15:15

Innovative Clinical Trial Conduct in The Age of Molecular and Cellular Medicine
Peter Fredette, Director, Oncology Site and Patient Networks, IQVIA

15:15 – 15:45

Novel Technologies for Bioprocess Development
Wei-Shou Hu, Professor, University of Minnesota

15:45 – 16:15

Bioprocess Design and Quality Assurance for Biosimilars
Andrew Chang, VP, Quality and Regulatory Compliance, Quality Intelligence & Inspection, Corporate Quality, Novo Nordisk; Former FDA Executive

16:15 – 16:30

Break

16:30 – 17:00

FDA Clinical and Regulatory Trends on Accelerating Approval of Biological Products
Kazem Kazempour, President and CEO, Amarex Clinical Research

17:00 – 17:30

Observations from Product Development in the Start-up World of Virotherapy and Cell Therapy
Lance Wong, Managing Director, Strand Bio

17:30 – 18:10

Panel Discussion
Moderator: Lee-Cheng LC Liu, President & CEO, EirGenix
Panelists: all speakers above

 

18:30 – 21:00

BioTaiwan 2018 Banquet

Ballroom A

 

July 19  (Thursday)

Venue: 3F, Bldg. A, CTBC Financial Park

08:30 – 09:00

Registration

BBA Session 3 - Intelligent Precision Medicine for Next-Generation Healthcare

Ballroom A

09:00 - 09:05

Welcome & Opening Remarks
Moderator: Chii-Wann Lin, Vice President and General Director, Biomedical Technology and Device Research Laboratories, ITRI

09:05 - 09:15

Guest of Honor Remarks
Fong-Chin Su, Deputy Minister, Ministry of Science and Technology, Taiwan / CEO, Biomedical Industrial Innovation Promotion (BIIP) 

09:15 - 09:50 Current trend for Dx Innovation in the Era of Big Data-based Precision Medicine
Yiu-Lian Fong, Global Head, Diagnostic Innovation, Research & Early Dev, and Lab Operation, Janssen

09:50 - 10:25

Precision Medicine: Innovation focused on patients
Thorsten Gutjahr, Global Head of Companion Diagnostics, Head of Oncology Companion Diagnostic Unit, AstraZeneca

10:25 - 10:40

Break

10:40 - 11:15

Time if of the Essence: Partnering for Success in Precision Medicine
Edward Rosen, President and Chief Executive Officer, Elucida Oncology

11:15 - 12:00

Panel Discussion
Moderator: Chii-Wann Lin, Vice President and General Director, Biomedical Technology and Device Research Laboratories, ITRI
Panelists: all speakers above &
                Jarret Su, Head of Healthcare, KPMG Taiwan

 

Luncheon - Sharing the Experience of Biotech Success

Ballroom A

12:15 - 12:20 Welcome Remarks
Johnsee Lee, Chairman, Taiwan Bio Industry Organization
12:20 - 12:30 Opening Remarks
Government Representative (Inviting)
12:30 - 13:50 Sharing the Experience of Biotech Success

 

BBA Session 4 - Novel Technologies for Precision Medicine Applications

Ballroom A

14:10 – 14:15

Welcome & Opening Remarks
Moderator: Chung-Hsiun Wu, CEO, Development Center for Biotechnology (DCB)

14:15 – 14:50 A World without Disease – An Innovative Approach to Health Care
Ben Wiegand, Global Head, World Without Disease Accelerator, Johnson & Johnson

14:50 – 15:25

Real World Evidence in Precision Medicine
Alvin Tan, Executive Director, Real World & Late Phase, APAC Operation, Syneos Health

15:25 – 16:00

Genomic Profiling for Identifying Drug Targets
Bin Tean Teh, Deputy Director, National Cancer Centre of Singapore 

16:00 – 16:15 Break

16:15 – 16:50

Biomarkers in Drug Development
Lisa Ooi, Scientific Director, ASLAN Pharmaceuticals

16:50 – 17:25

Perspectives of Intelligent Precision Medicine in the AI/Big Data Era
Michael Chang, CEO, Synergies Intelligent Systems

17:25 – 18:10

Panel Discussion
Moderator: Chung-Hsiun Wu, CEO, Development Center for Biotechnology (DCB)
Panelists: all speakers above

 

July 19  (Thursday)

Venue: 3F, Bldg. A, CTBC Financial Park

08:30 – 09:00

Registration

BBA Session 5 -  Nurturing Innovation and Startups through Creative Investment

Ballroom B

09:00 – 09:05

Welcome & Opening Remarks
Session Chair: Jo Shen, Venture Partner, Vivo Capital

09:05 – 09:30

Funding of New Drug Development Companies in Taiwan
Jo Shen, Venture Partner, Vivo Capital

09:30 – 10:10

Global Biotech Investment Trend
Hingge Hsu, Partner, NEST.Bio Venture

10:10 – 10:20

Break

10:20 – 10:50

Venture Capital’s Perspectives of Biotech Business
Stella Xu, Managing Director, Quan Capital

10:50 – 11:20

The Necessity of Private Equity in Taiwan Biotech Business
Andrew Lin, Chairman, Lotus Pharmaceutical

11:20 – 12:10

Panel Discussion
Moderator: Jo Shen, Venture Partner, Vivo Capital
Panelists: all speakers above

12:20 – 14:00

Luncheon

BBA Session 6 - Achieving Transformational Growth through IPO and M&A

Ballroom B

14:10 – 14:15

Welcome & Opening Remarks
Session Chair: Hong-Jen Chang, Chairman, Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA)

14:15 – 14:20

Guest of Honor Speech
Cheng-Mount Cheng, Vice Chairman of Financial Supervisory Commission, Taiwan

14:20 – 14:30 Overview on Global IPO Markets
Audrey Tseng, Deputy Chairman of PwC Taiwan.

14:30 – 14:55

Taiwan IPO Market Trends in Biotechnology
Frank Kuo, Chief Corporate Banking Officer, Yuanta Financial Holding

14:55– 15:20

Healthcare and Biotech Investments Trend in Asia
Bin Li, Chief Executive Officer, Ally Bridge LB Healthcare Fund

15:20 – 15:45

Trends in Taiwan Biotech Innovation and TLC’s Winning Experience
George Yeh, President, Taiwan Liposome Company (TLC) 

15:45 – 16:15

Panel Discussion
Moderator: Hong-Jen Chang, Chairman, Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA)
Panelists: all speakers above

16:15 – 16:30

Break

16:30 – 16:35

Welcome & Opening Remarks (M&A)
Session Chair: Hong-Jen Chang, Chairman, Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA)

16:35 – 17:00

M&A Trends and Outlook for Health Industries
Lily Wong, Partner, PwC Taiwan / Managing Director, PwC Financial Advisory Services

17:00 – 17:25

Strategic Investment Considerations from a Pharma Sector Perspective
Takafumi Horii, President & General Manager, Takeda Pharmaceuticals Taiwan

17:25 – 17:50 Need-Driven Innovation and Investment in Medical Technology
Lifei Cheng, Vice President, Medtronic Greater China

17:50 – 18:20

Panel Discussion
Moderator: Lily Wong, Partner, PwC Taiwan / Managing Director, PwC Financial Advisory Services
Panelists: all speakers above

 

July 20  (Friday)

Venue: 3F, Bldg. A, CTBC Financial Park

08:30 – 09:00

Registration

BBA Session 7 – Opportunities & Challenges of Cross Strait Collaborations

Ballroom A

09:00 – 09:10

Opening Remarks
Session Chair: Grace Yeh, President & CEO, PharmaEngine

09:10 – 09:35

Navigating through Regulatory Framework
Joseph Cho, Former Managing Director, RDPAC

09:35 – 10:00

A Winning Strategy to Develop New Products
Jen Chen, Chairman, Genovate Biotechnology

10:00 – 10:25

Creating Synergy through Cross Strait Collaborations
Wendy Huang, President & CEO, Lumosa Therapeutics

10:25 – 10:40

Break

10:40 – 11:05

How NIH/NCI Support Innovative Drug Development and Precision Medicine Trials
Heng Xie, Chief Medical Officer, Shenzhen Salubris Pharmaceuticals

11:05 – 11:30 Opportunity of Developing Generics through Cross-Strait Collaboration
Benjamin Li, CEO, Lee’s Pharmaceutical Holdings

11:30 – 12:10

Panel Discussion - Opportunities & Challenges of Cross Strait Collaborations
Moderator: Grace Yeh, President & CEO, PharmaEngine
Panelists: all speakers above & Haibo Qian, Vice President, Simcere Pharmaceutical Group

 

July 20  (Friday)

Venue: 3F, Bldg. A, CTBC Financial Park

BBA Session 8 – Southeast Asia Opportunities Conference

Ballroom A

13:30 – 13:45

Welcome & Opening Remarks
Session Chair: Jaw-Jou Kang, Dean, School of Pharmaceutical Sciences, National Yang-Ming University

13:45 – 14:10 Thailand Market Opportunity and Update Regulation Policy
Sarissa Chansatchanali, General Manager, SYMGENS

14:10 – 14:35

Current Philippine Market for Follow-on Biologics and Biosimilars
Tomas Luke Marcelo Agana III, President, Phil. Chamber of the Pharmaceutical Industry

14:35 – 15:00 Investment and Business Opportunities in Biotech, Life Sciences and Medical Technology in Malaysia
Nurullydia Ahmad, Director, Malaysian Investment Development Authority (MIDA), Taipei

15:00 – 15:25

Indonesia Pharmaceutical Landscape 
Iwan Koswara, Director, PT Harsen Laboratories

15:25 – 15:40

Break

15:40 – 16:05

Open Innovation to Drive Biopharmaceutical and Biosimilar Collaboration Among Emerging Countries 
Songpon Deechongkit, Managing Director, Abinis Co., Ltd. Bangkok Thailand

16:05 –16:30

Biosimilars in Malaysia - An Overview
David Ho, Chairman and Managing Director, Hovid Berhad

16:30 –16:55

Building ASEAN Drug Development Strategies – Vietnam
Yannick Willebois, Regional Senior BD Manager, DKSH Own Brands

16:55 –17:30 Panel Discussion
Moderator: Jaw-Jou Kang, Dean, School of Pharmaceutical Sciences, National Yang-Ming University
Panelists: speakers & Yu-Pei, Wang, Chairman, TPMDA; General Manager, NANG KUANG PHARMACEUTICAL

17:30

Networking

 

July 20  (Friday)

Venue: 3F, Bldg. A, CTBC Financial Park

08:30 – 09:00

Registration

BBA Session 9 – Advanced Biotherapies

 

Ballroom B

09:00 – 09:05

Opening Remarks
Session Chair: Timothy Lu, Associate Professor, MIT

09:05 – 09:35

Engineering Adaptive Cell and Gene Therapies
Timothy Lu, Associate Professor, MIT

09:35 – 10:05

Challenges and Prospects of CAR T Cell in Solid Tumors
Huamao Wang, Co-Founder & COO, CARsgen Therapeutics

10:05 – 10:20

Break

10:20 – 10:50

The Cell Therapy Industry in Japan
Akihiro Shimosaka, Chairperson, Asian Cellular Therapy Organization

10:50 – 11:20

Topic
Omar Duramad, Director of Immunology, REGiMMUNE

11:20 – 12:10

Panel Discussion
Moderator: Timothy Lu, Associate Professor, MIT
Panelists: all speakers above

 

Special Session -
    B.E.S.T. INNOVATION SYMPOSIUM - Business Engineering and Surgical Technology
    From Inception to Market Success: Advices from Around the Globe 

Ballroom B

13:30 – 15:50 Welcome Remarks
Eugene CHEN, Entrepreneur, BEST Course Director
Wayne HUANG, Vice Dean., IRCAD-Taiwan
Johnsee Lee, Chairman, Taiwan Bio Industry Organization
 
OPENING LECTURE
Vision and Mission of Biomedical Industry Innovation Program
Chih-Hwa Lin, COO, Biomedical Industry Innovation Program, MOST

Medical Device Innovation and Incubation Platform: IRCAD-Taiwan
Wayne HUANG, Vice Dean., IRCAD-Taiwan
 
Driving Disruption: A Fantastic Voyage 
Silvana PERRETTA, B.E.S.T. Executive Director, Director of web-based education, IHU Strasbourg
 
The Surgeon Innovator: From Idea to Product
Amir ZSOLD, Visionary surgeon and Entrepreneur Medical Director, Assia Medical
 
Human vs Machine: The Future of Robotic’s
Stefano STRAMIGIOLI, Professor and chair of Advance Robotics, University of Twente, The Netherlands
 
Financing Your Emerging Enterprise in Changing Times: Tales from an Investor and Entrepreneur
Eugene CHEN, Entrepreneur, BEST Course Director
 
Innovations Through Design Thinking in Health: IDEO Case Studies
Farzad AZIMPOUR, MD, Director of Health, Biodesigner and Cardiologist, IDEO
15:50 – 16:30 CLOSING LECTURE
In Praise of Dissenters and Non Conformists: How Original Business Thinking Moves the World
Denis McWILLIAMS, President and Chief Commercial Officer, Apollo Endosurgery